Endovia Health Sciences, Inc. (SBEV)
NYSE
Closed
Oct 12, 2026
Day's Range
0.140052 wk Range
0.1400Overview - SBEV - Endovia Health Sciences, Inc.
Key Statistics
Valuation
Enterprise Value
8.61M
P/E (Trailing)
‪-0.0030‬
P/E (Forward)
‪-2.14‬
PEG Ratio
‪0.000031‬
Price / Sales (TTM)
‪348.16‬
Price / Book
‪-0.02‬
EV / EBITDA
‪-0.59‬
Profitability
Profit Margin
‪23.12%‬
Operating Margin
‪-165,372.49%‬
Return on Assets
‪-77.00%‬
Return on Equity
‪164.92%‬
Ownership
Shares Outstanding
4.03M
Float
6.25M
Short % of Shares Outstanding
‪16.81%‬
Held by Insiders
‪0.0070%‬
Held by Institutions
‪4.33%‬
Price stats
50-Day Avg
‪0.4671‬
200-Day Avg
‪1.90‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SBEV - Endovia Health Sciences, Inc.
Peers - SBEV - Endovia Health Sciences, Inc.
Peer Comparison
Compared with companies in Beverages - Wineries & Distilleries listed on NYSE.
Profile Summary - SBEV - Endovia Health Sciences, Inc.
About
Endovia Health Sciences, Inc. is a health sciences company focused on cannabinoid-based pharmaceutical, veterinary, and consumer wellness products. The company develops and commercializes differentiated health technologies across regulated human and animal health markets, with current emphasis on commercial…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
